BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28402440)

  • 1. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
    Wang T; Cai H; Zheng W; Michel A; Pawlita M; Milne G; Xiang YB; Gao YT; Li HL; Rothman N; Lan Q; Shu XO; Epplein M
    Clin Infect Dis; 2017 May; 64(10):1380-1386. PubMed ID: 28402440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study.
    Dong LM; Shu XO; Gao YT; Milne G; Ji BT; Yang G; Li HL; Rothman N; Zheng W; Chow WH; Abnet CC
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3075-8. PubMed ID: 19861525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Varga MG; Wang T; Cai H; Xiang YB; Gao YT; Ji BT; Pawlita M; Waterboer T; Zheng W; Shu XO; Epplein M
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):342-344. PubMed ID: 29263184
    [No Abstract]   [Full Text] [Related]  

  • 5. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
    Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
    Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
    J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.
    Jang J; Wang T; Cai H; Ye F; Murphy G; Shimazu T; Taylor PR; Qiao YL; Yoo KY; Jee SH; Kim J; Chen SC; Abnet CC; Tsugane S; Zheng W; Shu XO; Pawlita M; Park SK; Epplein M
    Int J Cancer; 2020 Aug; 147(3):777-784. PubMed ID: 31745972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori blood biomarker for gastric cancer risk in East Asia.
    Cai H; Ye F; Michel A; Murphy G; Sasazuki S; Taylor PR; Qiao YL; Park SK; Yoo KY; Jee SH; Cho ER; Kim J; Chen SC; Abnet CC; Tsugane S; Cai Q; Shu XO; Zheng W; Pawlita M; Epplein M
    Int J Epidemiol; 2016 Jun; 45(3):774-81. PubMed ID: 27170766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fruit and vegetable consumption, Helicobacter pylori antibodies, and gastric cancer risk: A pooled analysis of prospective studies in China, Japan, and Korea.
    Wang T; Cai H; Sasazuki S; Tsugane S; Zheng W; Cho ER; Jee SH; Michel A; Pawlita M; Xiang YB; Gao YT; Shu XO; You WC; Epplein M
    Int J Cancer; 2017 Feb; 140(3):591-599. PubMed ID: 27759938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of urinary prostaglandin E2 metabolite and pancreatic cancer risk.
    Cui Y; Shu XO; Li HL; Yang G; Wen W; Gao YT; Cai Q; Rothman N; Yin HY; Lan Q; Xiang YB; Zheng W
    Int J Cancer; 2017 Dec; 141(12):2423-2429. PubMed ID: 28815606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
    Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study.
    Palli D; Masala G; Del Giudice G; Plebani M; Basso D; Berti D; Numans ME; Ceroti M; Peeters PH; Bueno de Mesquita HB; Buchner FL; Clavel-Chapelon F; Boutron-Ruault MC; Krogh V; Saieva C; Vineis P; Panico S; Tumino R; Nyrén O; Simán H; Berglund G; Hallmans G; Sanchez MJ; Larrãnaga N; Barricarte A; Navarro C; Quiros JR; Key T; Allen N; Bingham S; Khaw KT; Boeing H; Weikert C; Linseisen J; Nagel G; Overvad K; Thomsen RW; Tjonneland A; Olsen A; Trichoupoulou A; Trichopoulos D; Arvaniti A; Pera G; Kaaks R; Jenab M; Ferrari P; Nesi G; Carneiro F; Riboli E; Gonzalez CA
    Int J Cancer; 2007 Feb; 120(4):859-67. PubMed ID: 17131317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
    Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
    Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet, Helicobacter pylori strain-specific infection, and gastric cancer risk among Chinese men.
    Epplein M; Zheng W; Li H; Peek RM; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Xiang YB; Shu XO
    Nutr Cancer; 2014; 66(4):550-7. PubMed ID: 24666234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between pork consumption, CagA status and IL-1B-31 genotypes in gastric cancer.
    Wang XQ; Terry PD; Cheng L; Yan H; Wang JS; Wu WA; Hu SK
    World J Gastroenterol; 2014 Jul; 20(25):8151-7. PubMed ID: 25009387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
    Parsonnet J; Friedman GD; Orentreich N; Vogelman H
    Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.